Global Diabetes Care Devices Market by Product Type (Blood Glucose Monitoring Devices and Insulin Delivery Devices), by End User (Hospitals, Homecare Setting and Others) and by Geography - Opportunities & Forecast 2018-2025
発行: GMI Research
Diabetes care devices are utilized to screen the level of glucose into a diabetic patient's body. These devices also used in delivery of insulin into the patient's body. Advances in diabetes treatment and technology over the past several decades have fundamentally transformed the lives of millions of people with diabetes globally.
Diabetes disease is a global concern and socioeconomic issue that affects several million of person each year. Diabetes Care Devices is widely used in diagnosis and treatment of diabetes, blood glucose monitoring devices and insulin delivery devices have been broadly adopted worldwide to treat a diabetes. For example, In 2015, according to The International Diabetes Federation (IDF) seventh Edition, approximately 29.6 million of the adult population suffered from diabetes in in the South and Central America regions out of which about 39.0% were undiagnosed.
Diabetes Care Devices market growth is mainly driven by factors such as growing prevalence of diabetes, growing prevalence of obesity, rising diagnosis rate in emerging countries, technological advancements in the field of diabetes devices. In addition, rising disposable income in emerging countries and government aids are also helping to increase treatment seeking rate which further increases demand of Diabetes Care Devices which is expected to bolster revenue growth of the market during the forecast period. However, inadequate reimbursement scenario in emerging counties, lack of awareness about new diabetes care devices may hinder the growth of this market during the forecast period.
North-America is expected to dominate the market, followed by Europe attributed to wing to the reimbursement facilities, and presence of large number of companies which aid in product availability. Asia Pacific region is expected to exhibit higher growth rate during the forecast period due to the presence of large number of people with diabetes in this region and developing healthcare facilities are expected to fuel the market growth. Improvement in the healthcare infrastructure by increased government and private funding in emerging economies is expected to boost the growth of the market.
Various notable players operating the Diabetes Care Devices market include Abbott Laboratories, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd, Terumo Corporation, Glaxosmithkline Plc, Medtronic, Johnson & Johnson, Becton, Dickinson and Company, Dexcom, Inc., Sanofi and others.
The ‘Global Diabetes Care Devices market’ has been segmented based on product type, end user and key geographies. Based on Product type, the market comprises of Blood Glucose Monitoring Devices and Insulin Delivery Devices. This research report on Diabetes Care Devices market provides in-depth analysis of the global Diabetes Care Devices market based on product type, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for Diabetes Care Devices market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent development in the market.
The global diabetes care devices market is segmented on the basis of product type, end user and geography:
North America Diabetes Care Devices Market by End User Hospitals Homecare Setting Others
Europe Diabetes Care Devices Market by End User Hospitals Homecare Setting Others